Establishment Labs Expands Breast Augmentation Tech with New Product Lines

Establishment Labs Holdings Inc. (NASDAQ: ESTA) highlighted advancements in its breast augmentation technology at the 11th World Symposium on Ergonomic Implants in Istanbul, Turkey, attracting over 1,000 plastic surgeons from 57 countries. The event featured 127 scientific presentations, including data supporting the company’s Breast Tissue Preservation technology and Minimally Invasive Platform. Chief Executive Officer Peter Caldini emphasized the platform’s growing adoption, citing a 11% annual growth in the augmentation market, as cited by the American Society of Plastic Surgeons. The company also announced new sizes and supporting tools for its Mia and Preservé products, expanding its product line to better serve surgeons and patients. Notably, the company has delivered more than five million Motiva devices since 2010 and operates manufacturing facilities in Costa Rica, serving over 100 countries. Dr. Troy Pittman, a board-certified plastic surgeon and author, contributed to a Aesthetic Surgery Journal supplement on breast tissue preservation, reinforcing the foundation of the Minimally Invasive Platform. The symposium included a review of the first published U.S. multicenter clinical experience with Preservé, underscoring the technology’s evolving role in breast augmentation.